Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Democrats Will Blame the GOP for Rural Healthcare. Big Pharma Is the One Killing It.
Democrats will spend 2026 blaming Republicans for every healthcare complaint coming out of rural America. What they will not mention is that the party actually working to dismantle the program keeping rural hospitals stocked with cancer and HIV…
Sun Pharma Q1FY27 Profit Jumps 27% on India Growth, Innovative Medicines
Sun Pharmaceutical Industries announced a significant 27 per cent year-on-year jump in consolidated net profit for Q1FY27, reaching Rs 2,894.7 crore, propelled by strong performance in the Indian market and robust growth in its innovative medicine…
Sun Pharma withdraws multiple eye drop products as precautionary measure
A copy of the confidential letter issued by Sun Pharma Distributors Ltd on July 17 to distributors, accessed by ANI, states that there is a withdrawal of Eye Drops 5ML BKC FREE Lotepred-5ML, etc. “Withdrawal of Product - Depopred2ML…
Edgestream Partners L.P. Sells 37,986 Shares of Royalty Pharma PLC $RPRX
Edgestream Partners L.P. lessened its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 36.2% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 66,942 shares of the biopharmaceutical company's…
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Average Rating of 'Buy' from Analysts
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) has been given a consensus recommendation of 'Buy' by the ten analysts that are currently covering the stock, Marketbeat Ratings reports. Eight analysts have…
First Trust Advisors LP Acquires 18,905 Shares of Ascendis Pharma A/S $ASND
First Trust Advisors LP lifted its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 154.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,135 shares of…
Janus Henderson Group PLC Sells 82,739 Shares of NewAmsterdam Pharma Company N.V. $NAMS
Janus Henderson Group PLC lessened its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 3.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The…
RGUHS becomes first government university to unveil revised BPharm syllabus
With a view to bridging the gap between the pharma industry and academia, Rajiv Gandhi University of Health Sciences (RGUHS) unveiled a revised BPharm syllabus, becoming the first government university in India to do so, according to a release.
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?
The State Street Health Care Select Sector SPDR ETF (XLV -0.59%) provides broad exposure to the S&P 500 healthcare sector, whereas the Invesco Nasdaq Biotechnology ETF (IBBQ -1.84%) offers a targeted focus on biotechnology and pharmaceutical…
1 Top Wall Street Analyst Thinks This Stock Could Soar 95% Over the Next 12 Months. Here's Why I Agree.
BridgeBio Pharma (BBIO -2.50%) has already been one of biotech's biggest winners over the past two years (up 209% as of July 31). Yet Barclays analyst Eliana Merle believes the rally may not be over. Merle recently reiterated her overweight rating…
Andhra poised to emerge as a major manufacturing hub: PM Narendra Modi
4 min read Bengaluru, Hyderabad Make us preferred source on Google PRIME MINISTER Narendra Modi on Saturday said Andhra Pradesh is poised to emerge as a major manufacturing hub under the leadership of Chief Minister N Chandrababu Naidu. Addressing…
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
The State Street Health Care Select Sector SPDR ETF (XLV -0.59%) offers broad exposure to the S&P 500 healthcare sector at a low cost, whereas the Invesco Biotechnology & Genome ETF (PBE -1.64%) targets a concentrated niche of biotechnology…
Dr Reddy's gets USFDA nod for rituximab biosimilar
Pharma major Dr Reddy's Laboratories has secured approval from the U.S. Food and Drug Administration (FDA) for its rituximab biosimilar, a biosimilar to Rituxan (rituximab), for the US. market. The approval further strengthens Dr. Reddy's growing…
Uttar Pradesh trade show 2026 aims to boost global manufacturing and exports
With the objective of establishing Uttar Pradesh as a leading hub of global trade, manufacturing and exports, the fourth edition of the Uttar Pradesh International Trade Show (UPITS) will be held from 25 to 29 September at the India Expo Center and…
Donostia San Sebastian Klasikoa: Remco Evenepoel wins for a fourth time
Remco Evenepoel (Red Bull-Bora-Hansgrohe) has claimed a record fourth victory at Donostia San Sebastian Klasikoa, outsprinting late-race breakaway companion Richard Carapaz (EF Education-EasyPost) at the finish line in San Sebastián. 'Fourth…
Receive a Daily briefing on Pharma Industry News
Get Started